Literature DB >> 6648854

Factors influencing the size distribution of aerosols from jet nebulisers.

M M Clay, D Pavia, S P Newman, S W Clarke.   

Abstract

The size distribution of saline and bronchodilator (terbutaline) aerosol droplets generated from four widely used jet nebulisers (Acorn, Upmist, Turret, and Inspiron Mini-neb) has been measured with a Malvern 2200 Laser Particle Sizer. The mass median diameter of aerosol droplets generated by each nebuliser was strongly influenced by the driving flow rate of compressed air. By increasing the flow rate from 4 to 8 1 min-1 mass median diameters were halved (p less than 0.01) and there was an increase in the mass of aerosol within the optimum respirable range (less than 5 micron). To achieve this range the following individual flow rates were required: Turret 4 1 min-1, Acorn and Upmist 6 1 min-1, and Inspiron Mini-neb 8 1 min-1. A significant inverse relation (p less than 0.001) was found between mass median diameter and the geometric standard deviation, indicating that the aerosols were smaller but more heterodisperse at high flow rates. Changes in drug concentration had little effect on aerosol size. In 72% of the nebulisations followed to dryness there was no significant change in mass median diameter during the course of nebulisation and in the remainder it was less than 1.3 micron.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648854      PMCID: PMC459652          DOI: 10.1136/thx.38.10.755

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Operating characteristics of some compressed-air nebulizers.

Authors:  T T Mercer; M I Tillery; H Y Chow
Journal:  Am Ind Hyg Assoc J       Date:  1968 Jan-Feb

2.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

Review 3.  Clinical aerosols. I. Characterization of aerosols and their diagnostic uses.

Authors:  R V Lourenço; E Cotromanes
Journal:  Arch Intern Med       Date:  1982-11

4.  Inhaled drugs in the prevention of asthma.

Authors:  A J Woolcock
Journal:  Am Rev Respir Dis       Date:  1977-02

5.  Bronchodilator drugs.

Authors:  J W Paterson; A J Woolcock; G M Shenfield
Journal:  Am Rev Respir Dis       Date:  1979-11

6.  Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols.

Authors:  D L Swift
Journal:  Am Rev Respir Dis       Date:  1980-11

Review 7.  Aerosol therapy in acute and chronic respiratory disease.

Authors:  W F Miller
Journal:  Arch Intern Med       Date:  1973-01
  7 in total
  31 in total

1.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.

Authors:  J H Dennis; S C Stenton; J R Beach; A J Avery; E H Walters; D J Hendrick
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

Review 2.  Aerosol deposition in the alveolar space.

Authors:  G Huchon
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Drug delivery from jet nebulisers.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

4.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

5.  Selecting and using nebuliser equipment.

Authors:  A H Kendrick; E C Smith; R S Wilson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 6.  The science of nebulised drug delivery.

Authors:  C O'Callaghan; P W Barry
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

7.  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.

Authors:  Paul Zarogoulidis; Ellada Eleftheriadou; Iordanis Sapardanis; Vasiliki Zarogoulidou; Helliel Lithoxopoulou; Theodoros Kontakiotis; Nikolaos Karamanos; George Zachariadis; Maria Mabroudi; Athanasios Zisimopoulos; Kostantinos Zarogoulidis
Journal:  Invest New Drugs       Date:  2011-07-08       Impact factor: 3.850

8.  Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size.

Authors:  Beena G Sood; Jennifer Peterson; Monica Malian; Robert Galli; Maria Geisor-Walter; Jon McKinnon; Jody Sharp; Krishna Rao Maddipati
Journal:  Pharmacol Res       Date:  2007-10-02       Impact factor: 7.658

9.  Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes.

Authors:  G L Larsen; H Renz; J E Loader; K L Bradley; E W Gelfand
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.